Keri Dame

Keri Dame is a Senior Scientist at United Therapeutics Corporation, with prior experience as a Scientist at the FDA's Center for Drug Evaluation and Research, where contributions included experimental modeling of drug safety. Keri completed a Post-Doctoral Research Fellowship at the FDA, focusing on integrating hiPSC-derived lineages to evaluate in vitro drug effects, and participated in interdisciplinary collaborations employing artificial intelligence for drug toxicity detection. Education includes a Ph.D. in Genetics & Genomics from Boston University School of Medicine, where research centered on thyroid specification mechanisms, and a B.S. in Biology from the University of Southern Maine. Previous roles also include a Medical Laboratory Technologist at Good Start Genetics and senior laboratory technician positions at Boston University, demonstrating a solid foundation in molecular genetics and diagnostics.